Mongoose Bio

Cell & Gene Therapy · Integrative & Alternative Medicine

Overview

Delivering clinically proven epigenetically programmed memory T Cells to fight cancer. Mongoose Bio is an early-stage clinical company revolutionizing the delivery of T cell precision therapies against common and rare solid tumors.

Funding and backers

Total raised
$1M
1 round on record
Latest round
$1M
Venture round · Oct 2023 · 3 yr ago
Team
51-200
employees, estimated range
The money's age
Long since its last round
36 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 12, 2023 Raised a round Venture round $1M · SEC Form D 2023 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2023 $1M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Mongoose Bio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Cassian YeeExecutive Officer, DirectorSEC Form D
Norman GreenbergExecutive Officer, DirectorSEC Form D
Shailbala SinghExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Waypoint Bio11-50 employees
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
Redefining Complement Therapies. Complement Therapeutics is a clinical-stage biotechnology company advancing precision therapies for…
T-knife TherapeuticsFounded 2018 · 51-200 employees
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer.
ALKemist BioVenture round $7.5M · 2 yr ago · 11-50 employees
ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune…
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Signadori BioFounded 2024
Signadori Bio is a preclinical stage biopharmaceutical company developing a next generation in vivo monocyte immunotherapy to treat solid…

Financials

Total raised
$1M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $1M Details

People

Cassian Yee
Executive Officer, Director
Norman Greenberg
Executive Officer, Director
Shailbala Singh
Executive Officer
Peter Hoang
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Houston United States
HQ
Address
50-200 est. staff
2450 Holcombe Blvd. Ste. 200, Houston, TX 77021
company site